Karen Prange Insider Trading
Get free email notifications about insider trading for Karen Prange.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen Prange. Karen Prange is a SVP&Pres, Uro & Pelvic Health in BOSTON SCIENTIFIC CORP ($BSX) and a SVP&Pres, Uro & Women's Health in BOSTON SCIENTIFIC CORP ($BSX) and a Director in CANTEL MEDICAL CORP ($CMN) and a EVP&CEO Gl.AH.Med.Den.Sur.Grp in HENRY SCHEIN INC ($HSIC) and a Director in AtriCure, Inc. ($ATRC) and a Director in NEVRO CORP ($NVRO).
Address: ONE BOSTON SCIENTIFIC PLACE NATICK 01760-1537 MA
Companies in which Karen Prange is an Insider
AtriCure, Inc.
Trading Symbol: ATRCIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen Prange: Director
Holdings: 10,103 shares
Current Value: $172,054
Latest Transaction: May 24 2021
$ATRC Market Capitalization: $567.72M
$ATRC Previous Close: $17.03
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BOSTON SCIENTIFIC CORP
Trading Symbol: BSXIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen Prange: SVP&Pres, Uro & Pelvic Health, SVP&Pres, Uro & Women's Health
Holdings: 38,395 shares
Current Value: $968,706
Latest Transaction: Mar 08 2016
$BSX Market Capitalization: $34.39B
$BSX Previous Close: $25.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CANTEL MEDICAL CORP
Trading Symbol: CMNIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen Prange: Director
Holdings: 1,935 shares
Latest Transaction: Jul 31 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HENRY SCHEIN INC
Trading Symbol: HSICIndustry: WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
Position of Karen Prange: EVP&CEO Gl.AH.Med.Den.Sur.Grp
Holdings: 62,902 shares
Current Value: $10,314,670
Latest Transaction: Mar 06 2018
$HSIC Market Capitalization: $13.17B
$HSIC Previous Close: $163.98
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEVRO CORP
Trading Symbol: NVROIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen Prange: Director
Holdings: 2,703 shares
Current Value: $252,271
Latest Transaction: Dec 18 2019
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Karen Prange
Sentiment: All, ATRC, BSX, CMN, HSIC, NVRO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2021 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 1,749 | 0 | 10,103 | 8.4 K to 10.1 K (+20.94 %) |
May 24 2021 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 1,749 | 0 | 10,103 | 8.4 K to 10.1 K (+20.94 %) |
Jul 31 2020 | CMN | CANTEL MEDICAL COR ... | Prange Karen | Director | Grant | A | 0.00 | 1,935 | 0 | 1,935 | 0 to 1.9 K |
May 22 2020 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 2,452 | 0 | 8,354 | 5.9 K to 8.4 K (+41.55 %) |
Dec 18 2019 | NVRO | NEVRO CORP | Prange Karen | Director | Grant | A | 0.00 | 2,703 | 0 | 2,703 | 0 to 2.7 K |
Dec 05 2019 | ATRC | AtriCure, Inc. | Prange Karen | Director | Grant | A | 0.00 | 5,902 | 0 | 5,902 | 0 to 5.9 K |
Mar 06 2018 | HSIC | HENRY SCHEIN INC | Prange Karen | EVP&CEO Gl.AH.Med.D ... | Grant | A | 0.00 | 19,558 | 0 | 62,902 | 43.3 K to 62.9 K (+45.12 %) |